assistant professor, Urmia university of medical sciences
Ali Golchin is a prominent researcher and academic in the fields of stem cell biology, cell-based therapies, and regenerative medicine. With a passion for pushing the limits of medical science, he is dedicated to advancing the potential of cell therapy in treating a wide range of diseases. He holds a Ph.D. in Applied Cell Sciences from Shahid Beheshti Medical University, Tehran, and has made significant contributions through research, publications, and clinical trials. He currently serves as an Assistant Professor at Urmia University of Medical Sciences, Iran, and is involved in multiple editorial roles for renowned scientific journals. Recognized for his excellence, he ranks among the top 2% of scientists according to Stanford University’s rankings. His work is recognized worldwide for its innovative approaches in stem cell treatments, wound healing, and regenerative medicine, where he continues to lead groundbreaking research projects.
Profile
Scholar
Orcid
Scopus
Education
Ali Golchin’s academic journey is marked by a diverse and advanced educational background. He earned his Ph.D. in Applied Cell Sciences from Shahid Beheshti Medical University in Tehran, Iran (2019), with a thesis on the use of human buccal fat pad-derived mesenchymal stem cells and curcumin for wound healing. Prior to that, he completed his DVM (Doctor of Veterinary Medicine) at the University of Tabriz, Iran (2015), where he focused on ammonium chloride concentrations in the in-vitro fertilization of ovine oocytes. Golchin further pursued advanced knowledge through a Master of Business Administration in Healthcare (2019) and a Master’s in Medical Education (2025) from Shahid Beheshti Medical University. His educational journey reflects his commitment to integrating both medical and management expertise to advance research in regenerative medicine and stem cell therapies. Golchin’s academic career has laid a strong foundation for his leadership in the field of applied cell sciences.
Experience
Ali Golchin brings over 5 years of experience as an Assistant Professor at the Medical School of Urmia University of Medical Sciences, where he specializes in regenerative medicine, stem cell therapies, and applied cell sciences. In addition to his academic role, he has made significant contributions to research as the editor-in-chief for Open Dermatology Journal and section editor for Stem Cell Reviews and Reports. He has led numerous groundbreaking projects on stem cell-based treatments, including clinical trials for wound healing and the therapeutic use of fibroblasts and exosomes in dermatological disorders. His experience extends beyond academia as he has developed several research initiatives funded by Iranian universities. Golchin is known for his interdisciplinary approach, collaborating with national and international researchers to advance cell-based therapies and regenerative medicine. His extensive background enables him to guide students and professionals in the fields of tissue engineering and stem cell research.
Awards and Honors
Ali Golchin’s career has been distinguished by numerous awards and recognitions for his outstanding contributions to stem cell research and regenerative medicine. He is ranked among the top 2% of scientists globally, as recognized by Elsevier and Stanford University in 2022, 2023, and 2024. Golchin was also named the top researcher in both his province and university in 2021-2022. He has received prestigious awards from the National Elite Foundation of Iran for his exceptional work in medical research. Additionally, his editorial roles and extensive publications in leading scientific journals highlight his international recognition and impact. These accolades reflect his commitment to advancing the fields of cell therapy and regenerative medicine. Golchin’s achievements underscore his dedication to excellence in scientific research, teaching, and innovation, making him a respected leader in his field.
Research Focus
Ali Golchin’s research focus lies in the development and application of cell-based therapies and regenerative medicine. His primary area of interest includes the therapeutic potential of stem cells, particularly mesenchymal stem cells, for treating chronic diseases, promoting tissue regeneration, and enhancing wound healing. Golchin has conducted pioneering research on the use of stem cells derived from human buccal fat pads and their integration into nanofiber scaffolds for wound healing. His work also explores the combination of stem cells with gene therapy, exosome applications, and the development of biocompatible scaffolds for tissue engineering. Golchin has a deep interest in the clinical translation of stem cell therapies, evaluating their effects on various medical conditions, including dermatological diseases, COVID-19, and cancer. His research also focuses on the creation of advanced nanomaterials and hydrogels to enhance cell delivery systems. Through these efforts, Golchin aims to improve the effectiveness and safety of regenerative treatments.
Conclusion
Ali Golchin stands out as a highly accomplished researcher whose contributions to stem cell biology, regenerative medicine, and cell-based therapies have had a profound impact on the medical field. His impressive leadership roles, global recognition, and active involvement in groundbreaking research make him a strong contender for the Best Researcher Award. While there are opportunities for further growth, particularly in global collaboration and public engagement, his consistent achievements in both research and education demonstrate a remarkable ability to push the boundaries of science. Therefore, his qualifications, experience, and dedication to advancing healthcare position him as an exceptional candidate.
Publication
Author: A Golchin, E Seyedjafari, A Ardeshirylajimi
Title: Mesenchymal stem cell therapy for COVID-19: present or future
Year: 2020
Citation: 419
Author: A Golchin, TZ Farahany
Title: Biological products: cellular therapy and FDA approved products
Year: 2019
Citation: 186
Author: Z Niknam, A Jafari, A Golchin, F Danesh Pouya, M Nemati, …
Title: Potential therapeutic options for COVID-19: an update on current evidence
Year: 2022
Citation: 167
Author: A Golchin, TZ Farahany, A Khojasteh, F Soleimanifar, A Ardeshirylajimi
Title: The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review
Year: 2019
Citation: 163
Author: A Golchin, S Hosseinzadeh, A Ardeshirylajimi
Title: The Exosomes Released from Different Cell types and Their Effects in Wound Healing
Year: 2018
Citation: 110
Author: NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, …
Title: Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Year: 2024
Citation: 97
Author: SL Moradi, A Golchin, Z Hajishafieeha, MM Khani, A Ardeshirylajimi
Title: Bone tissue engineering: Adult stem cells in combination with electrospun nanofibrous scaffolds
Year: 2018
Citation: 92
Author: A Golchin
Title: Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility
Year: 2022
Citation: 88
Author: A Azari, A Golchin, MM Maymand, F Mansouri, A Ardeshirylajimi
Title: Electrospun polycaprolactone nanofibers: current research and applications in biomedical application
Year: 2021
Citation: 81
Author: P Kangari, TZ Farahany, A Golchin, S Ebadollahzadeh, A Salmaninejad, …
Title: Enzymatic antioxidant and lipid peroxidation evaluation in the newly diagnosed breast cancer patients in Iran
Year: 2018
Citation: 63
Author: A Golchin, F Shams, F Karami
Title: Advancing mesenchymal stem cell therapy with CRISPR/Cas9 for clinical trial studies
Year: 2020
Citation: 57
Author: A Golchin, S Hosseinzadeh, M Staji, M Soleimani, A Ardeshirylajimi, …
Title: Biological behavior of the curcumin incorporated chitosan/poly (vinyl alcohol) nanofibers for biomedical applications
Year: 2019
Citation: 57
Author: A Golchin, S Hosseinzadeh, A Jouybar, M Staji, M Soleimani, …
Title: Wound healing improvement by curcumin‐loaded electrospun nanofibers and BFP‐MSCs as a bioactive dressing
Year: 2020
Citation: 47